Viva Biotech Holdings (1873) Price & Analysis

Compare

1 Followers

1873 Stock Chart & Stats

Day’s Range― - ―

52-Week RangeHK$0.47 - HK$2.12

Previous CloseN/A

Volume129.00K

Average Volume (3M)5.89M

Market Cap

HK$3.24B

Enterprise ValueHK$2.17B

Total Cash (Recent Filing)¥155.55M

Total Debt (Recent Filing)¥222.96M

Price to Earnings (P/E)18.0

Beta2.25

Next Earnings

Aug 28, 2025

EPS EstimateN/A

Last Dividend Ex-Date

Jun 16, 2021

Dividend YieldN/A

Share Statistics

EPS (TTM)0.08

Shares Outstanding2,131,775,400

10 Day Avg. Volume1,420,911

30 Day Avg. Volume5,892,439

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)0.00

Price to Cash Flow (P/CF)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

---

Viva Biotech Holdings News

PremiumCompany Announcements

Viva Biotech Holdings Announces Annual General Meeting with Key Resolutions

11d ago

1873

PremiumCompany Announcements

Viva Biotech Holdings Announces Board Composition and Committee Roles

1M ago

1873

PremiumCompany Announcements

Viva Biotech Holdings Forms Nomination Committee to Strengthen Board Governance

1M ago

1873

PremiumCompany Announcements

Viva Biotech Reports Improved Profitability Amid Revenue Decline

1M ago

1873

PremiumCompany Announcements

Viva Biotech’s Subsidiary Passes Fourth FDA Inspection, Boosting Global Expansion

1M ago

1873

PremiumCompany Announcements

Viva Biotech Holdings Schedules Board Meeting to Review Annual Results

2M ago

1873

PremiumCompany Announcements

Viva Biotech Holdings Announces Positive Profit Turnaround for 2024

2M ago

1873

PremiumCompany Announcements

Viva Biotech Announces Subsidiary Restructuring and CFO Changes

7M ago

1873

See All HK:1873 News

---

Financials

Income Statement >

Options Prices

Currently, No data available

---

Ownership Overview

―

Insiders

0.28%

Mutual Funds

0.01% Other Institutional Investors

99.65% Public Companies and

Individual Investors

Detailed Ownership Overview >

1873 FAQ

What was Viva Biotech Holdings’s price range in the past 12 months?

Viva Biotech Holdings lowest stock price was HK$0.47 and its highest was HK$2.12 in the past 12 months.

What is Viva Biotech Holdings’s market cap?

Viva Biotech Holdings’s market cap is HK$3.24B.

When is Viva Biotech Holdings’s upcoming earnings report date?

Viva Biotech Holdings’s upcoming earnings report date is Aug 28, 2025 which is in 115 days.

How were Viva Biotech Holdings’s earnings last quarter?

Viva Biotech Holdings released its earnings results on Mar 27, 2025. The company reported HK$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.026.

Is Viva Biotech Holdings overvalued?

According to Wall Street analysts Viva Biotech Holdings’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Viva Biotech Holdings pay dividends?

Viva Biotech Holdings pays a Annually dividend of HK$0.009 which represents an annual dividend yield of N/A. See more information on Viva Biotech Holdings dividends here

What is Viva Biotech Holdings’s EPS estimate?

Viva Biotech Holdings’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Viva Biotech Holdings have?

Viva Biotech Holdings has 2,131,775,400 shares outstanding.

What happened to Viva Biotech Holdings’s price movement after its last earnings report?

Viva Biotech Holdings reported an EPS of HK$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.124%.

Which hedge fund is a major shareholder of Viva Biotech Holdings?

Currently, no hedge funds are holding shares in HK:1873

---

Viva Biotech Holdings Stock Smart Score

Outperform

Technicals

Fundamentals

Return on Equity

4.47%

Trailing 12-Months

Asset Growth

-8.52%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Viva Biotech Holdings

Viva Biotech Holdings (stock code: 1873) is a China-based company primarily engaged in providing drug discovery services to biotechnology and pharmaceutical companies worldwide. The company operates in the sectors of Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO), offering a wide range of integrated services including structure-based drug discovery, medicinal chemistry, and drug development services. Viva Biotech leverages its proprietary technology platforms and experienced scientific team to accelerate the drug discovery process for its clients.

---

1873 Stock 12 Month Forecast

Average Price Target

―

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"NaN":"―"}},"plotLines":[{"color":"rgba(0,0,0,0)","label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":null,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">―</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">―</span>\n  </div></div>","useHTML":true}}],"tickPositions":[null,null,null,null,null],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2022","6":"Feb<br/>2023","9":"May<br/>2023","12":"Jan<br/>2024","25":"Jan<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.01,0.9323076923076923,0.8546153846153846,0.7769230769230769,0.6992307692307692,0.6215384615384615,0.5438461538461539,0.46615384615384614,0.3884615384615384,0.3107692307692307,0.23307692307692296,0.15538461538461534,0.07769230769230762,{"y":null,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,{"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":2.11,"date":1659312000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.86,"date":1661990400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.33,"date":1664582400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.26,"date":1667260800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.65,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.75,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.97,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.66,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.49,"date":1680307200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.43,"date":1682899200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":1.43,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.5,"date":1685577600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.01,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >